(02) 9926 4726

News and Event

Funding Awarded By Sydney Vital

The research projects below were awarded by Sydney Vital. We will post their progress when it is submitted and to keep up-to-date with our scholarships, funding and awards, check out our grant schemes.

#AwardeeInstitutionSupervisorResearch TitleAmount
Awarded
1Jerikho BulanadiKolling Institute of Medical ResearchProf Ross SmithChemotherapeutic prodrugs incorporated within recombinant high density lipoprotein nanoparticles as a modality of targeted delivery.$15,000
2Emma ColvillSydney University Medical SchoolProf Paul KeallThe bench-to-bedside clinical implementation of real-time targeted radiotherapy for prostate cancer$15,000
3Grace GiffordHaematology and Anatomical Pathology Departments. Royal North Shore Hospital, St Leonards, SydneyDr William StevensonGene expression profiling of high grade B-cell lymphomas with NanoString nCounter technology. Validation of a novel diagnostic platform and implementation into clinical use for prognostication and therapeutic decision-making.$15,000
4Dr Anthony GloverKolling Institute of Medical Research, Royal North Shore HospitalProf Stanley SidhuNoncoding RNAs as tumour suppressors in adrenal cancer: Unlocking the mechanisms to improve patient outcomes.$15,000
5Diana HatoumFaculty of Science, UTS SydneyDr Najah NassifA Role for p14ARF-p53 in Treatment Resistance and Recurrence in Hormone-dependent Breast Cancer.$15,000
6Samuel BrennanFaculty of Science, UTS SydneyDr Rose Martiniello-WilksDevelopment of a non-invasive liquid biopsy for prostate cancer: Identification of unique exosome microRNA (exomiR) signatures in patient body fluids for cancer diagnosis and prognosis.$15,000
7Ben HarrisSydney Medical School, University of SydneyDr Kellie CharlesInvestigating mechanisms of chemoresistance to platinum drugs mediated by systemic inflammation.
$15,000
8Adrian LeeBill Walsh Translation Cancer Research Laboratory, Kolling InstituteDr Viive Howell"Do molecular aberrations in the tumour predict for venous thrombotic episodes in patients with
glioblastoma multiforme?"
$15,000
9Jaynish ShahSydney Medical School, University of SydneyProf Deborah MarshInvestigating the complexity of p53 pathways in ovarian cancer: are non-coding RNAs the key?$15,000
Read more

Implementing excellent supportive care evidence into action

 

A presentation about scalp cooling, preventing chemotherapy induced alopecia.

Courtesy of Professor Fran Boyle

Read more

Grading NETs

A presentation on a grading scheme for combined somatostatin receptor (SSR) and FDG imaging. 

Read more

Implementing Change Through MDT

 

Read more

Rectal Cancer: Question Time

New Paradigms in Rectal Cancer

 

Read more

Supportive care, end stage tumour, and end-of life management – CLOSED

CALL FOR EOI’S FOR PILLAR LEADERS

Sydney Vital is seeking 2 individuals to act as leader for Pillar 4:
“Supportive care, end stage tumours, and end-of life management”. The Pillar’s aims are deliberately broad to allow scope to explore and exploit strengths within the partner organisations. The Pillar provides base funding of $10 k p.a. (which can be further leveraged) to support activities to bring Pillar members together to develop new programs of research, both basic science and clinical, and to expand networks and collaborations. Ideally, the Pillars would have outputs that impact on the T1, T2 and T3 domains of translational research as defined by the CINSW, or the Sydney Vital Flagship Programs 1, 2, or 3 (www.sydneyvital.org.com). The Pillar leader is ideally an early to mid-career researcher who is currently developing their research portfolio.

Read More: Pillar 4 EOI_ 2015
Closing Date for EOI’s: Friday, 5th June 2015

Read more

PET/CT scanning in Lung Cancer

Read more